MARKET

IRMD

IRMD

Iradimed Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.21
+0.32
+0.97%
After Hours: 33.21 0 0.00% 16:01 05/27 EDT
OPEN
32.96
PREV CLOSE
32.89
HIGH
33.57
LOW
32.81
VOLUME
36.28K
TURNOVER
0
52 WEEK HIGH
55.92
52 WEEK LOW
26.54
MARKET CAP
417.14M
P/E (TTM)
40.05
1D
5D
1M
3M
1Y
5Y
Iradimed appoints John Glenn as chief financial officer
Medical device maker Iradimed (NASDAQ:IRMD) said on Thursday it had appointed John Glenn as the company's Chief Financial Officer effective on or before June 20. Glenn, 60, has over 30
Seekingalpha · 1d ago
iRadimed Appoints John Glenn as CFO
MT Newswires · 1d ago
What You Need To Know About IRadimed Corporation's (NASDAQ:IRMD) Investor Composition
If you want to know who really controls IRadimed Corporation ( NASDAQ:IRMD ), then you'll have to look at the makeup of...
Simply Wall St. · 05/11 10:25
After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for iRadimed (IRMD)
iRadimed (IRMD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend r...
Zacks · 05/10 13:35
iRadimed (IRMD) is an Incredible Growth Stock: 3 Reasons Why
iRadimed (IRMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks · 05/06 16:45
70 Biggest Movers From Friday
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners.
Benzinga · 05/02 09:46
ANIX and CPS among mid-day movers
Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN)
Seekingalpha · 04/29 16:48
IRadimed (IRMD) Q1 Earnings and Revenues Top Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of 4.76% and 0.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/29 12:25
More
No Data
Learn about the latest financial forecast of IRMD. Analyze the recent business situations of Iradimed Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average IRMD stock price target is 45.00 with a high estimate of 50.00 and a low estimate of 40.00.
High50.00
Average45.00
Low40.00
Current 33.21
EPS
Actual
Estimate
0.080.170.250.33
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 128
Institutional Holdings: 6.04M
% Owned: 48.07%
Shares Outstanding: 12.56M
TypeInstitutionsShares
Increased
28
232.49K
New
33
458.74K
Decreased
23
304.84K
Sold Out
8
106.29K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Chairman/President/Chief Executive Officer/Founder/Director
Roger Susi
Chief Financial Officer/Chief Operating Officer/Secretary
Chris Scott
Vice President/Director of Sales/Director of Marketing
Randy Waddell
Controller
Matt Garner
Independent Director
Monty Allen
Independent Director
James Hawkins
Independent Director
Anthony Vuoto
No Data
No Data
About IRMD
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

Webull offers kinds of Iradimed Corp stock information, including NASDAQ:IRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRMD stock methods without spending real money on the virtual paper trading platform.